Retrospective Study
Copyright ©The Author(s) 2025.
World J Transplant. Sep 18, 2025; 15(3): 104308
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.104308
Table 1 Demographic and clinical parameters of the study population
Parameter
n = 78
Age of recipients (years)29.57 ± 10.11
Recipient gender
    Males49 (62.8)
    Females29 (37.2)
Age of donors (years)34.53 ± 9.09
Donor gender
    Males46 (59.0)
    Females32 (51.0)
Donor relation
Siblings46 (58.9)
Parents14 (17.9)
Spouses17 (21.8)
Offspring1 (1.3)
HLA mismatches
1-221 (27.0)
3-437 (47.4)
5-620 (25.6)
Duration of hemodialysis (months)14.01 ± 15.48
End-stage kidney disease cause
    Unknown48 (61.5)
    Chronic glomerulonephritis20 (25.6)
    Stone disease5 (6.4)
    Bladder outlet obstruction and neurogenic bladder3 (3.8)
Table 2 Donor-specific antibodies against human leukocyte antigen class positivity and rejection episodes
Parameter
Mean DSA MFI
DSA Class I, n = 36 (46.2%)3286.58 ± 4530.50; Range: 933-9994
DSA Class II, n = 35 (44.8%)3207.47 ± 4219.00; Range: 1041-9383
DSA Class I and II, n = 7 (8.9%)Class I = 3245.00 ± 2117.00; Range: 5515-6518
Class II = 2101.00 ± 959.00; Range: 2336- 3610
In rejection (n = 8)
Class I, n = 2 (25.0%)Median = 4994 (IQR = 3922-4994)
Class II, n = 6 (75.0%)Median = 2718 (IQR = 1221-5173)
In no rejection (n = 63)
Class I, n = 34 (48.5%)Median = 2481 (IQR = 1732-4136)
Class II, n = 29 (41.4%)Median = 3088 (IQR = 1479- 5249)